Total trials
598
Active
145
Phase 3
45
Total enrollment
236,847
Pipeline matrix
Showing 24 of 24 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Low molecular weight heparin | — | — | — | — | — | 1 | |
| Blood sample | — | — | — | — | 3 | ||
| Saliva sample | — | — | — | — | 3 | ||
| Botulinum toxin type A | — | — | — | — | — | 1 | |
| ICG | — | — | — | — | — | 1 | |
| Stood sample | — | — | — | — | — | 1 | |
| high flow oxygen therapy rate adjusted of lung volumes measured | — | — | — | — | — | 1 | |
| Apllication of cream | — | — | — | — | — | 1 | |
| Pembrolizumab | — | — | — | — | — | 1 | |
| Pembrolizumab and Chemotherapy drugs | — | — | — | — | — | 1 | |
| Direct Oral Anticoagulants | — | — | — | — | — | 1 | |
| Low-dose aspirin | — | — | — | — | — | 1 | |
| Capsaicin 8% patch | — | — | — | — | — | 1 | |
| Baricitinib 4 MG Oral | — | — | — | — | — | 1 | |
| Baricitinib 2 MG Oral | — | — | — | — | — | 1 | |
| Propofol + analgesic drug | — | — | — | — | — | 1 | |
| Isoflurane + analgesic drug | — | — | — | — | — | 1 | |
| Urine sample | — | — | — | — | 2 | ||
| Cannabis oil | — | — | — | — | — | 1 | |
| Botulinum toxin | — | — | — | — | — | 1 | |
| Biologic sample | — | — | — | — | — | 1 | |
| biological sample | — | — | — | — | — | 1 | |
| matching genotype with phenotype | — | — | — | — | — | 1 | |
| Biological samples | — | — | — | — | — | 1 |
Next readouts
- 2025-09-14
- 2025-10-31
- 2025-12-22
- 2026-02-01
- 2026-06-22
- 2026-11
- 2027-03
- 2027-06
- 2027-07-13
- 2027-12
Top conditions
- Pulmonary Embolism13
- Venous Thromboembolism11
- Pruritus9
- Cystic Fibrosis9
- Polymyalgia Rheumatica8
- Chronic Obstructive Pulmonary Disease8
- Cerebral Palsy6
- COPD6
Frequently asked questions about University Hospital, Brest
- How many clinical trials does University Hospital, Brest have on ClinicalTrials.gov?
- University Hospital, Brest is listed as the lead sponsor on 598 clinical trials in ClinicalTrials.gov, 145 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University Hospital, Brest's trials are in Phase 3?
- 45 of University Hospital, Brest's trials are in Phase 3, spread across 24 active drug programs.
- What therapeutic areas does University Hospital, Brest focus on?
- University Hospital, Brest's most-studied conditions on ClinicalTrials.gov are Pulmonary Embolism, Venous Thromboembolism, Pruritus, Cystic Fibrosis, Polymyalgia Rheumatica.
- When are University Hospital, Brest's next clinical trial readouts?
- University Hospital, Brest has 10 upcoming primary-completion readouts tracked here; the soonest is “Comparison of an Inhaled Sedation Strategy to an Intravenous Sedation Strategy in Intensive Care Unit Patients Treated With Invasive Mechanical Ventilation”, expected around 2025-09-14.